Exosomes Derived from AT2R-Overexpressing BMSC Prevent Restenosis after Carotid Artery Injury by Attenuating the Injury-Induced Neointimal Hyperplasia

Xinliang Zou,Yi Liao,Zhihui Liu,Xiang Xu,Weiwei Sun,Haoran Qin,Haidong Wang,Jianping Liu,Tao Jing
DOI: https://doi.org/10.1007/s12265-022-10293-2
2022-01-01
Journal of Cardiovascular Translational Research
Abstract:Restenosis is a severe complication after percutaneous transluminal coronary angioplasty which limits the long-term efficacy of the intervention. In this study, we investigated the efficiency of exosomes derived from AT2R-overexpressing bone mesenchymal stem cells on the prevention of restenosis after carotid artery injury. Our data showed that AT2R-EXO promoted the proliferation and migration of vascular endothelial cells and maintained the ratio of eNOS/iNOS. On the contrary, AT2R-EXO inhibited the proliferation and migration of vascular smooth muscle cells. In vivo study proved that AT2R-Exo were more effectively accumulated in the injured carotid artery than EXO and Vehicle-EXO controls. AT2R-EXO treatment could improve blood flow of the injured carotid artery site more effectively. Further analysis revealed that AT2REXO prevents restenosis after carotid artery injury by attenuating the injury-induced neointimal hyperplasia. Our study provides a novel and more efficient exosome for the treatment of restenosis diseases after intervention.
What problem does this paper attempt to address?